DHX9-IN-19
DHX9-IN-19 (compound 3) is an orally active and potent inhibitor of DHX9. DHX9-IN-19 plays an important role in cancer research[1].
Product Specifications
CAS Number
2973400-78-9
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC(C)OC1=CN=C(C2=C(C)SC(C(NC3=CC(NS(=O)(C)=O)=CC(Cl)=C3)=O)=C2)N=C1
Molecular Formula
C20H21ClN4O4S2
Molecular Weight
480.99
References & Citations
[1]Accent Therapeutics, Inc. Assays for monitoring inhibition of RNA helicase DHX9 by measuring the level of Alu-mediated circular RNA in relation to cancer treatment. World Intellectual Property Organization, WO2024220373 A1 2024-10-24
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7167309 Inquire
Rabbit anti-Escherichia coli O1:K1/APEC RHMA Polyclonal Antibody
Sign In for Pricing
View Details